Results 221 to 230 of about 331,966 (252)
Some of the next articles are maybe not open access.
Medicare Spending on Anti–Vascular Endothelial Growth Factor Medications
Ophthalmology Retina, 2018To analyze Medicare Part B spending on anti-vascular endothelial growth factor (VEGF) medications.Observational cohort study using Medicare Part B claims data released by the Centers for Medicare and Medicaid Services.Medicare Part B beneficiaries and their providers.Data from 2011 through 2015 were used to analyze intravitreal injection claims for ...
openaire +2 more sources
Anti-Vascular Endothelial Growth Factor Monoclonal Antibodies
2009As tumors grow and metastasize, they require the formation of new blood vessels or angiogenesis. This process is regulated by a complex balance of pro- and antiangiogenic factors. One of these factors, vascular endothelial growth factor (VEGF), has been extensively studied and found to be an important stimulatory signal that drives angiogenesis.
Ernest S. Han, Bradley J. Monk
openaire +1 more source
Ocular Inflammation with Anti-Vascular Endothelial Growth Factor Treatments
Human Gene Therapy, 2021Shun-Yun, Cheng, Claudio, Punzo
openaire +2 more sources
Anti-Vascular Endothelial Growth Factor Treatment for Retinal Vein Occlusions
Ophthalmologica, 2012Retinal vein occlusion (RVO) encompasses two conditions: central RVO, in which the major outflow vessel of the retina is obstructed, and branch RVO, in which a proximal branch of the central retinal vein is obstructed. In both conditions, there is increased intraluminal and interstitial pressure throughout the retina drained by the obstructed vessels ...
openaire +2 more sources
Antivascular Endothelial Growth Factor
2015Michelle C. Liang, Jeffrey S. Heier
openaire +1 more source
Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
International Journal of Molecular Sciences, 2021Melanie Bruchard +2 more
exaly
Anti-Vascular Endothelial Growth Factor for Neovascular Glaucoma
2022Narine Viruni, Cindy X. Cai
openaire +1 more source
Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Cancer Treatment and Research Communications, 2022Oluwafemi Adeleke Ojo +2 more
exaly

